Ameloblastoma is a true neoplasm originating from the enamel organ, classified by clinical and histological types, with a notable prevalence in the mandible and a mean diagnosis age of 30-39 years. The tumor displays varying growth patterns and can have high recurrence rates, with management strategies ranging from enucleation to more aggressive surgical interventions. Malignant variants, including ameloblastic carcinoma, present significant challenges due to their aggressive nature and potential for metastasis, primarily to the lungs and cervical lymph nodes.